Anticancer Potential of Lichens' Secondary Metabolites. Review uri icon

Overview

abstract

  • Lichens produce different classes of phenolic compounds, including anthraquinones, xanthones, dibenzofuranes, depsides and depsidones. Many of them have revealed effective biological activities such as antioxidant, antiviral, antibiotics, antifungal, and anticancer. Although no clinical study has been conducted yet, there are number of in vitro and in vivo studies demonstrating anticancer effects of lichen metabolites. The main goal of our work was to review most recent published papers dealing with anticancer activities of secondary metabolites of lichens and point out to their perspective clinical use in cancer management.

publication date

  • January 5, 2020

Research

keywords

  • Antineoplastic Agents
  • Lichens
  • Plant Extracts

Identity

PubMed Central ID

  • PMC7022966

Scopus Document Identifier

  • 85078015336

Digital Object Identifier (DOI)

  • 10.3390/biom10010087

PubMed ID

  • 31948092

Additional Document Info

volume

  • 10

issue

  • 1